Preoperative cardiac risk assessment for non-cardiac surgery
Perioperative evaluation · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Preoperative cardiac assessment estimates perioperative cardiovascular risk by combining surgical risk, functional capacity and patient factors to guide testing and optimisation. The goal is to proceed safely, not to delay surgery with low-yield tests.
Red flags
- Unstable angina or recent MI
- Decompensated heart failure
- Symptomatic severe aortic stenosis
- Uncontrolled significant arrhythmia
- Recent coronary stent within the mandated DAPT window
Assessment
Differential diagnosis
- Stable coronary disease
- Unstable/active cardiac condition
- Decompensated heart failure
- Significant arrhythmia
- Severe valvular disease (especially aortic stenosis)
- Non-cardiac dyspnoea
Investigations
- Resting ECG in patients with cardiac risk factors for intermediate/high-risk surgery
- Echocardiogram if new murmur, dyspnoea or suspected LV dysfunction
- Functional capacity assessment (METs or validated questionnaire)
- NT-proBNP in selected higher-risk patients
- Troponin surveillance perioperatively in high-risk patients
- Stress imaging only if it will change management
Management
- Identify any active/unstable cardiac condition that mandates delay and treatment
- Classify the surgery's inherent cardiac risk (low, intermediate, high)
- Assess functional capacity — good capacity (≥4 METs) reassures without further testing
- Apply a validated risk index (e.g. RCRI) to estimate major cardiac risk
- Reserve non-invasive stress testing for poor/unknown capacity with elevated risk where results change management
- Continue beta-blockers and statins perioperatively if already established
- Do not start high-dose beta-blockers acutely before surgery
- Manage antiplatelet/anticoagulant therapy around the procedure with a defined plan
- Delay elective surgery after recent coronary stenting per DAPT timelines
- Optimise heart failure, arrhythmia and severe valve disease before elective surgery
- Plan perioperative troponin surveillance in high-risk patients
- Communicate the plan clearly to the surgical and anaesthetic team
Drugs & doses
Continue established beta-blocker (e.g. bisoprolol 2.5-10 mg PO OD) perioperatively
Continue statin (e.g. atorvastatin 40-80 mg PO OD) through surgery
Continue aspirin in most patients with coronary stents per heart-team advice
Bridging/withholding of anticoagulants per procedure-specific protocol
Avoid acute high-dose beta-blocker initiation pre-surgery
Disposition
Preoperative clinic and anaesthetic team coordination; cardiology referral for active cardiac conditions or complex decisions.
Complications & pitfalls
- Perioperative myocardial infarction/injury (MINS)
- Heart failure decompensation
- Stent thrombosis from premature DAPT cessation
- Arrhythmia
- Stroke and bleeding complications
Exam pearls
- Good functional capacity (≥4 METs) usually obviates further cardiac testing
- Do not initiate high-dose beta-blockade just before surgery (stroke/mortality risk)
- Only order stress tests that will actually change perioperative management
- Delay elective non-cardiac surgery after stenting per DAPT duration rules
- Perioperative troponin rises (MINS) carry prognostic weight even when asymptomatic
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.